# Multi-points and Full-thickness Biopsy in the Diagnosis of cCR After Neoadjuvant Therapy for Rectal Cancer

> **NCT04743102** · NA · RECRUITING · sponsor: **Beijing Chao Yang Hospital** · enrollment: 260 (estimated)

## Conditions studied

- Rectal Cancer
- Neoadjuvant Therapy
- Complete Remission
- Metastasis

## Interventions

- **PROCEDURE:** multi-points and full-thickness Biopsy
- **DIAGNOSTIC_TEST:** traditional cCR

## Key facts

- **NCT ID:** NCT04743102
- **Lead sponsor:** Beijing Chao Yang Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-01-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2023-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04743102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04743102, "Multi-points and Full-thickness Biopsy in the Diagnosis of cCR After Neoadjuvant Therapy for Rectal Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04743102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
